Furthermore, trials using mixed tocotrienols (Magosso et al., Pervez et al., and Pervez et al.)highlighted a range of effects, with improvements in ALT and AST and mild effects on hepatic steatosis, particularly when using doses around 200-300 mg twice daily [16,18,23]. The gene discussed is GPT; the disease is Hepatic steatosis.